ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TRML Tourmaline Bio Inc

13.48
-0.07 (-0.52%)
Last Updated: 12:21:20
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Tourmaline Bio Inc TRML NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -0.52% 13.48 12:21:20
Open Price Low Price High Price Close Price Prev Close
13.62 12.98 13.9299 13.55
more quote information »

Recent News

Date Time Source Heading
6/04/20249:08IHNWFeaturedElement79 Gold Corp Continues Fostering Local Community Engagement
5/23/202407:10GLOBETourmaline Bio to Present at the Jefferies Global Healthcare..
5/16/202407:00GLOBETourmaline Bio Initiates Clinical Development of TOUR006 for..
5/13/202416:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202407:15EDGAR2Form 8-K - Current report
5/13/202407:00GLOBETourmaline Bio Reports First Quarter 2024 Financial Results..
4/02/202407:00GLOBEAvalo Therapeutics Appoints Biotech Leaders to Board of..
3/19/202407:00GLOBETourmaline Bio Reports Fourth Quarter and Full Year 2023..
2/27/202407:30GLOBETourmaline Bio to Present at Upcoming Investor Conferences
2/14/202421:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202420:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/09/202416:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/01/202408:00GLOBETourmaline Bio to Present at the Guggenheim Healthcare Talks..
1/29/202416:01GLOBETourmaline Bio Announces Closing of $172.5 Million Public..
1/26/202416:12EDGAR2Form 8-K - Current report
1/26/202416:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/25/202407:00GLOBETourmaline Bio Announces Pricing of Public Offering of..
1/24/202421:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/24/202417:10EDGAR2Form 8-K - Current report
1/24/202416:05GLOBETourmaline Bio Announces Proposed Public Offering of Common..
1/08/202409:19EDGAR2Form 8-K - Current report
1/08/202407:00GLOBETourmaline Bio Announces Expected Upcoming Key Milestones..
12/15/202316:00GLOBETourmaline Bio added to the NASDAQ Biotechnology Index
12/14/202308:27EDGAR2Form 8-K - Current report
12/14/202307:30GLOBETourmaline Bio Appoints Dr. Clay Siegall as Chairman of the..
11/30/202308:25EDGAR2Form 8-K - Current report
11/01/202308:00GLOBETourmaline Bio to Present at Upcoming Investor Conferences
10/23/202320:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/23/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/23/202320:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/23/202320:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/23/202320:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/23/202320:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/23/202318:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/19/202317:37GLOBETourmaline Bio Announces Closing of Merger with Talaris..

Your Recent History

Delayed Upgrade Clock